申请人:Terumo Corporation
公开号:US04673684A1
公开(公告)日:1987-06-16
According to the invention, there are provided novel amide derivatives and 5-lipoxygenase inhibitors containing the same as an effective ingredient. The above-mentioned compounds of the invention have been demonstrated to posses 5-lipoxygenase-inhibiting activities. These compounds can inhibit the production of leucotrienes such as LTC.sub.4 and LTD.sub.4 which are allergy-inducing factors by inhibiting the activity of 5-lipoxygenase. Accordingly, the amide derivatives can be used as 5-lipoxygenase inhibitors effective for allergic asthma, allergic rhinitis and the like.
根据该发明,提供了新型酰胺衍生物和含有该衍生物作为有效成分的5-脂氧合酶抑制剂。该发明中提到的化合物已被证明具有5-脂氧合酶抑制活性。这些化合物可以通过抑制5-脂氧合酶的活性来抑制诸如LTC.sub.4和LTD.sub.4等过敏诱导因子的白三烯产生。因此,酰胺衍生物可用作对过敏性哮喘、过敏性鼻炎等有效的5-脂氧合酶抑制剂。